Company profile
Coya Therapeutics, Inc.
NASDAQ:COYABiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07161999 | phase2_3 | recruiting | 2025-10-01 | 2027-01-01 | Coya Therapeutics | Study of COYA 302 for the Treatment of ALS |
FDA applications (0)
No records yet.